🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Randomized Phase II Trial: Chest Wall RT Omission After Prosthetic Reconstruction

RecruitingPhase 2Ages 18 Years - 70 YearsFemaleSecond Affiliated Hospital, Zhejiang University, …
NCT06464913 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this randomized Phase II clinical trial is to test the effects of omitting chest wall radiotherapy (RT) after prosthetic reconstruction in early-stage breast cancer patients. The main questions it aims to answer are: * Can omitting chest wall RT after prosthetic reconstruction reduce the failure rate of breast reconstruction without significantly increasing the local recurrence rate? * Does this approach ensure an improvement in the quality of life for patients without sacrificing therapeutic effectiveness? Participants will: * Be randomly assigned to one of two groups. * One group will receive standard RT to the chest wall and supraclavicular and infraclavicular lymphatic drainage areas. * The other group will have chest wall RT omitted and will only receive RT to the supraclavicular and infraclavicular lymphatic drainage areas. * Participate in follow-up assessments to m

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Undergoes prosthetic reconstruction (including cold knife one-step prosthetic reconstruction or two-step expander-prosthetic reconstruction.); * Histologically confirmed invasive breast cancer patients with stage T1-2N1M0; * ECOG score of 0-1; * Indications for neoadjuvant therapy before surgery and adjuvant therapy after surgery. Exclusion Criteria: * Other metabolically active malignant tumors; * Severe dysfunction of heart, lung, liver, kidney, or other vital organs; * Uncontrolled diabetes or other endocrine diseases; * Known allergy to radiotherapy or chemotherapy drugs; * Pregnant or lactating women.
💊

What it tests

  • With or without chest wall RT
📍

Where

1 site
The Second Affiliated Hospital of Zhejiang University
Hangzhou, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy